RedHill Biopharma Provides Q3/2020 Results and Highlights, Including 300% Talicia Prescription Growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.42 -0.04 (8.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.46 | 52 Week High | $16.54 | |||
| Open | $0.46 | 52 Week Low | $8.10 | |||
| Day High | $0.47 | P/E | N/A | |||
| Day Low | $0.41 | EPS | $0.00 | |||
| Volume | 236,400 | |||||
